LBX2 and ovarian carcinoma: Based on our results presented in Figure 4E, we hypothesized that LBX2‐AS1 might participate in the development of ovarian cancer by inhibiting miR‐455‐5p and miR‐491‐5p, thus increasing the expression of E2F2 gene.